The Prostate Health Index (phi) is a blood test used to improve the detection of prostate cancer. It combines three different blood tests—total prostate-specific antigen (PSA), free PSA, and [-2]proPSA—into a single score to help determine the likelihood of prostate cancer. This test aims to reduce unnecessary biopsies in men with elevated PSA levels by providing more specific information about the risk of prostate cancer.
